PROSTAGLANDIN E1

Course overview

PROSTAGLANDIN E1 (PGE1) IS A MEDICATION USED IN THE MANAGEMENT OF ERECTILE DYSFUNCTION AND DUCTUS ARTERIOSUS IN NEONATES. IT IS A SMOOTH MUSCLE RELAXANT AND VASODILATOR. THIS ARTICLE OUTLINES THE INDICATIONS, MECHANISM OF ACTION, AND CONTRAINDICATIONS OF TAKING ALPROSTADIL AS A VALUABLE AGENT IN TREATING ERECTILE DYSFUNCTION AND NEONATAL CONGENITAL HEART DEFECTS. THIS ACTIVITY WILL HIGHLIGHT THE MECHANISM OF ACTION, ADVERSE EVENT PROFILE, AND OTHER KEY FACTORS (E.G., OFF-LABEL USES, DOSING, PHARMACODYNAMICS, PHARMACOKINETICS, MONITORING, RELEVANT INTERACTIONS) PERTINENT FOR MEMBERS OF THE HEALTHCARE TEAM IN THE TREATMENT OF PATIENTS WITH THE CONDITIONS AS MENTIONED ABOVE.